Clinical Edge Journal Scan

Protective Relationship Between Migraine and Cardiovascular Disease


 

Key clinical point: Migraine may have a protective effect against some cardiovascular diseases, such as coronary artery disease (CAD) and ischemic stroke, in this Mendelian randomization (MR) analysis, with coronary atherosclerosis (CA) and myocardial infarction (MI), reducing the risk for migraine in reverse MR analysis.

Major findings: Genetically predicted risk of migraine was associated with a lower risk for CAD (odds ratio [OR] 0.881; P = .023) and ischemic stroke (OR 0.912; P = .006). Reciprocally, CA (OR 0.865; P = .001) and MI (OR 0.798; P = .012) were associated with a lower risk for migraine.

Study details: This bidirectional MR study analyzed the causal effect of migraine on CVD using data from 873,341 and 554,569 individuals, and the causal effect of CVD on migraine using data from 484,598 and 463,010 individuals, using large-scale Genome-Wide Association Study databases.

Disclosure: The study was supported by the National Natural Science Foundation of China, and others. The authors reported no conflicts of interest.

Source: Duan X, Du X, Zheng G, et al. Causality between migraine and cardiovascular disease: A bidirectional Mendelian randomization study. J Headache Pain. 2024;25:130 (Aug 13) . doi: 10.1186/s10194-024-01836-w Source

Recommended Reading

Rimegepant Relieves Pain in Acute Migraine
Migraine ICYMI
Commentary: Migraine and Lifestyle Factors, September 2024
Migraine ICYMI
Humanized Monoclonal Antibody Reduces Migraine Frequency in Phase 2 Study
Migraine ICYMI
Does Migraine Increase the Risk for Parkinson Disease?
Migraine ICYMI
Ubrogepant Effectively Treats Migraine When Administered During Prodrome
Migraine ICYMI
Meta-Analysis Shows Increased Neck Pain and Disability in Migraine
Migraine ICYMI
Migraine and GDM Raise Risk for Major Cerebro- and Cardiovascular Events in Women
Migraine ICYMI
Long-term Safety of Intranasal Zavegepant for Acute Treatment of Migraine
Migraine ICYMI
Eicosapentaenoic Acid Is an Effective Adjunct Therapy for Chronic Migraine
Migraine ICYMI
Monthly or Quarterly Fremanezumab Effective Against Episodic Migraine
Migraine ICYMI